Moderna, Inc. (MRNA)
145.61
+1.84
(+1.28%)
USD |
NASDAQ |
Sep 16, 16:00
146.47
+0.86
(+0.59%)
After-Hours: 20:00
Moderna Market Cap : 58.10B for Sept. 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 15, 2026 | 57.36B |
| September 14, 2026 | 58.53B |
| September 11, 2026 | 57.44B |
| September 10, 2026 | 54.51B |
| September 09, 2026 | 54.11B |
| September 08, 2026 | 55.99B |
| September 04, 2026 | 58.07B |
| September 03, 2026 | 59.40B |
| September 02, 2026 | 60.17B |
| September 01, 2026 | 61.55B |
| August 31, 2026 | 56.00B |
| August 28, 2026 | 55.06B |
| August 27, 2026 | 56.97B |
| August 26, 2026 | 59.71B |
| August 25, 2026 | 63.37B |
| August 24, 2026 | 55.42B |
| August 21, 2026 | 57.91B |
| August 20, 2026 | 53.19B |
| August 19, 2026 | 69.58B |
| August 18, 2026 | 25.12B |
| August 17, 2026 | 25.72B |
| August 14, 2026 | 25.26B |
| August 13, 2026 | 25.40B |
| August 12, 2026 | 25.40B |
| August 11, 2026 | 24.17B |
| Date | Value |
|---|---|
| August 10, 2026 | 23.86B |
| August 07, 2026 | 23.61B |
| August 06, 2026 | 21.49B |
| August 05, 2026 | 22.45B |
| August 04, 2026 | 22.74B |
| August 03, 2026 | 22.00B |
| July 31, 2026 | 21.87B |
| July 30, 2026 | 23.11B |
| July 29, 2026 | 21.74B |
| July 28, 2026 | 22.27B |
| July 27, 2026 | 22.09B |
| July 24, 2026 | 21.47B |
| July 23, 2026 | 22.64B |
| July 22, 2026 | 23.05B |
| July 21, 2026 | 23.69B |
| July 20, 2026 | 23.62B |
| July 17, 2026 | 24.54B |
| July 16, 2026 | 25.07B |
| July 15, 2026 | 27.11B |
| July 14, 2026 | 26.77B |
| July 13, 2026 | 26.60B |
| July 10, 2026 | 27.10B |
| July 09, 2026 | 30.39B |
| July 08, 2026 | 29.30B |
| July 07, 2026 | 31.67B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Sarepta Therapeutics, Inc. | 2.086B |
| BioNTech SE | 24.08B |
| Twist Bioscience Corp. | 8.972B |
| Intellia Therapeutics, Inc. | 1.609B |
| Replimune Group, Inc. | 1.088B |
Market Cap Related Metrics
| PS Ratio | 25.73 |
| PEG Ratio | -2.940 |
| Price to Book Value | 8.593 |
| Price | 145.61 |
| Earnings Yield | -5.48% |
| PEGY Ratio | -2.940 |